Journal
CANCER RESEARCH
Volume 73, Issue 1, Pages 428-438Publisher
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-12-2095
Keywords
-
Categories
Funding
- National Science Council [NSC 101-2320-B-006-026-MY3, NSC 101-2325-B-006-018]
- Department of Health, Taiwan [DOH101-TD-PB-111-TM026]
- NSC [NSC 100-2319-B-001-002]
Ask authors/readers for more resources
alpha-Catulin is an oncoprotein that helps sustain proliferation by preventing cellular senescence. Here, we report that alpha-catulin also drives malignant invasion and metastasis. alpha-Catulin was upregulated in highly invasive non-small cell lung cancer (NSCLC) cell lines, where its ectopic expression or short-hairpin RNA-mediated attenuation enhanced or limited invasion or metastasis, respectively. alpha-Catulin interacted with integrin-linked kinase (ILK), a serine/threonine protein kinase implicated in cancer cell proliferation, antiapoptosis, invasion, and angiogenesis. Attenuation of ILK or alpha-catulin reciprocally blocked cell migration and invasion induced by the other protein. Mechanistic investigations revealed that alpha-catulin activated Akt-NF-kappa B signaling downstream of ILK, which in turn led to increased expression of fibronectin and integrin alpha v beta 3. Pharmacologic or antibody-mediated blockade of NF-kappa B or alpha v beta 3 was sufficient to inhibit alpha-catulin-induced cell migration and invasion. Clinically, high levels of expression of alpha-catulin and ILK were associated with poor overall survival in patients with NSCLC. Taken together, our study shows that alpha-catulin plays a critical role in cancer metastasis by activating the ILK-mediated Akt-NF-kappa B-alpha v beta 3 signaling axis. Cancer Res; 73(1); 428-38. (C)2012 AACR.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available